CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...
Hosted on MSN10mon
Improving cancer immunotherapy by prolonging T-cell survivalMore information: Anwesha Kar et al, CD38–RyR2 axis–mediated signaling impedes CD8 + T cell response to anti-PD1 therapy in cancer, Proceedings of the National Academy of Sciences (2024).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback